Spinout Active LTD

Company profile

Cotton Mouton Diagnostics Ltd

CMD

Your endotoxin testing partner

CRN
09343496
Founded
2014
Age
11

Overview

Browse spinouts
Legal name
COTTON MOUTON DIAGNOSTICS LTD
Region
Wales
Registered address
8 CAE GWYRDD
GREENMEADOW SPRINGS
CARDIFF
WALES
CF15 7AB
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

7 events
19 Dec
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

19 Jun
2026

Accounts With Accounts Type Total Exemption Full

Accounts Analysed

AA | Transaction MzUyNzMyMDE4NWFkaXF6a2N4

Published 19 Jun 2026 13:06

05 Dec
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

11 Oct
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzOTE4ODc2NWFkaXF6a2N4

Published 11 Oct 2024 03:07

05 Dec
2014

Incorporated

Inception

Company registered at Companies House

Spinout profile

2 entries

Company description

Cotton Mouton Diagnostics develops new devices that uses antibodies on magnetic beads and rotating magnetic fields to detect DNA, RNA and toxins in blood samples such as malaria.

Project impact

TBC

Cotton Mouton Diagnostics
2014
Cotton Mouton Diagnostics
2014

Public funding

4 awards
First funded
2015
Funded years
2015, 2020, 2021
Age at first award
0 years

Projects

2021 Innovation Loans Lead participant

AlphaBET - Endotoxin detection for the 21st Century

1 Apr 2021 to 31 Mar 2022

Awarded
£371,167
Total cost £371,167

Bacteria do not have to be whole and 'alive' to cause problems. If certain cell components enter the blood stream the consequences can be life threatening. Endotoxin is one such component. Found in high-concentrations in the cell wall of many bacteria, including those resident in the human GI tract, endotoxin is the most potent mediator of inflammation kn...

2020 Feasibility Studies Lead participant

Development of a serology test for COVID-19 screening

1 Jun 2020 to 31 Mar 2021

Awarded
£74,073
Total cost £74,073

Since the realisation that a new coronavirus was responsible for a cluster of pneumonia cases in China on 9thJanuary, more than 2 million cases and 135,000 deaths have been reported across the globe. The so-called 'COVID-19' pandemic has put healthcare systems under enormous pressure and has resulted in global economic collapse as a result of quarantine a...

2015 Study Lead participant

Cotton Mouton

1 Sep 2015 to 28 Feb 2017

Awarded
£496,606
Total cost £496,606

Cotton Mouton Diagnostics Ltd CMD is developing a highly innovative magneto optical sensing platform that exploits changes in the rotational behaviour of magnetic reporters naturally occurring or artificially introduced observed via the Cotton Mouton effect. CMD is applying the technology to the field of in vitro point of care PoC diagnostics. Long runnin...

2015 Launchpad Lead participant

Magneto-optical multiplex diagnostics

1 Aug 2015 to 31 Jan 2017

Awarded
£67,298
Total cost £112,164

Cotton Mouton Diagnostics (CMD) is a start-up company based in South Wales. CMD's vision is to deliver innovative, fit-for-purpose, point-of-care diagnostic technologies based upon a unique magneto-optical sensing mechanism. The technology has been successfully field-tested as a malaria diagnostic, relying on detection of a parasite-derived magnetic marke...

Product types

Feasibility Studies Innovation Loans Launchpad Study